One Hand on the Now, One Hand on the Next
Businesses need to pursue the Big Idea that will make them successful in the long term while working on the operations that will make that Big Idea a reality.
Source: forbes.com
Hint Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hint Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hint Inc Today - Breaking & Trending Today
U.S. FDA Approves First Therapeutic Indication for Revance's DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
- Provides Revance entry into the $2.5 billion U.S. therapeutic neuromodulator market.1 - Approval expands the DAXXIFY® label to include efficacy data over the 52-week ASPEN repeat dose clinical... -Today at 08:04 am- MarketScreener
Source: marketscreener.com
Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update
- Q2 total revenue of $58.1 million, a YoY increase of 104.9%.- Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%.- Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of 47.1%.- Bolstered financial position with $100 million net proceeds from ATM program and $50 million in notes available to be...
Source: pharmiweb.com
Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update
- Q2 total revenue of $58.1 million, a YoY increase of 104.9%. - Q2 RHA® Collection revenue of $31.8 million, a YoY increase of 24.7%. - Q2 DAXXIFY® revenue of $22.6 million, a QoQ increase of...
Source: marketscreener.com
Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update
- Q1 total revenue of $49.3 million, a YoY increase of 95.3%. - Q1 RHA® Collection revenue of $30.3 million, a YOY increase of 45.3%. - Q1 DAXXIFY® revenue of $15.4 million, driven by PrevU... | May 9, 2023
Source: marketscreener.com